The weekly litigation news digest is live. Subscribe now

IP Verse

Methods And Systems For Purifying Non-Complexed Botulinum Neurotoxin - EP2490986

The patent EP2490986 was granted to Revance Therapeutics on Apr 24, 2024. The application was filed on Oct 20, 2010 under application number EP10825598A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2490986

REVANCE THERAPEUTICS
Application Number
EP10825598A
Filing Date
Oct 20, 2010
Status
Patent Maintained As Amended
Mar 22, 2024
Publication Date
Apr 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIGMay 2, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20010910432
DESCRIPTIONUS20040793138
DESCRIPTIONUS20050072026
DESCRIPTIONUS20050073307
DESCRIPTIONUS20070824393
DESCRIPTIONUS2003008367
DESCRIPTIONUS2006228780
DESCRIPTIONUS7354740
DESCRIPTIONUS7452697
INTERNATIONAL-SEARCH-REPORTUS2003008367
INTERNATIONAL-SEARCH-REPORTUS2004259197
INTERNATIONAL-SEARCH-REPORTUS2005238669
INTERNATIONAL-SEARCH-REPORTUS2006228780
INTERNATIONAL-SEARCH-REPORTUS2007037257
OPPOSITIONUS2006228780
OPPOSITIONWO0074703
OPPOSITIONWO2011050072
SEARCHUS2006228780

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents